These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 2877573)
1. Efficacy and safety of famotidine in the management of benign gastric ulcers. Lyon DT Am J Med; 1986 Oct; 81(4B):33-41. PubMed ID: 2877573 [TBL] [Abstract][Full Text] [Related]
3. Famotidine (MK-208) in the treatment of gastric ulcer. Results of a multicenter double-blind controlled study. Paoluzi P; Torsoli A; Bianchi Porro G; Lazzaroni M; Barbara L; Corinaldesi R; Blasi A; Mangiameli A; Carratelli L; Cheli R Digestion; 1985; 32 Suppl 1():38-44. PubMed ID: 2866135 [TBL] [Abstract][Full Text] [Related]
4. Randomized, double-blind comparison of famotidine with ranitidine in treatment of acute, benign gastric ulcer disease. Community-based study coupled with a patient registry. Brazer SR; Tyor MP; Pancotto FS; Brice RS; Garbutt JT; Wildermann NM; Harrell FE; Pryor DB; Liss CL; Root JK Dig Dis Sci; 1989 Jul; 34(7):1047-52. PubMed ID: 2568247 [TBL] [Abstract][Full Text] [Related]
5. [Accelerated healing of ulcus ventriculi by a single evening dose of famotidine. Results of an Austrian-German-Italian multicenter study]. Dammann HG; Barbara L; Bianchi-Porro G; Cheli R; Hentschel E; Müller P; Paoluzzi P; Simon B; Walter TA Schweiz Med Wochenschr; 1985 Apr; 115(14):484-8. PubMed ID: 2859653 [TBL] [Abstract][Full Text] [Related]
6. Famotidine once-a-day in the therapy of acute, benign gastric ulcer: a worldwide experience. Simon B; Müller P; Dammann HG J Clin Gastroenterol; 1987; 9 Suppl 2():19-22. PubMed ID: 2887614 [TBL] [Abstract][Full Text] [Related]
7. A multicenter, randomized, double-blind study comparing famotidine with ranitidine in the treatment of active duodenal ulcer disease. McCullough AJ Am J Med; 1986 Oct; 81(4B):17-24. PubMed ID: 2877570 [TBL] [Abstract][Full Text] [Related]
8. Famotidine in the USA: a review of efficacy studies. Gitnick G J Int Med Res; 1989; 17 Suppl 1():17A-24A. PubMed ID: 2566539 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacy of irsogladine maleate and famotidine for the healing of gastric ulcers after Helicobacter pylori eradication therapy: a randomized, controlled, prospective study. Murakami K; Okimoto T; Kodama M; Tanahashi J; Mizukami K; Shuto M; Abe H; Arita T; Fujioka T Scand J Gastroenterol; 2011 Mar; 46(3):287-92. PubMed ID: 21073372 [TBL] [Abstract][Full Text] [Related]
10. Famotidine versus ranitidine for the short-term treatment of duodenal ulcer. Simon B; Dammann HG; Jakob G; Miederer SE; Müller P; Ottenjann R; Paul F; Scholten T; Schütz E; Seifert E Digestion; 1985; 32 Suppl 1():32-7. PubMed ID: 2866134 [TBL] [Abstract][Full Text] [Related]
11. Famotidine: proven once-a-day treatment for gastric ulcer. Dammann HG; Walter TA; Hentschel E; Muller P; Simon B Scand J Gastroenterol Suppl; 1987; 134():29-33. PubMed ID: 3310200 [TBL] [Abstract][Full Text] [Related]
12. Famotidine. The ACG Committee on FDA-Related Matters with primary authorship by G. Friedman. American College of Gastroenterology. Am J Gastroenterol; 1987 Jun; 82(6):504-6. PubMed ID: 2883885 [TBL] [Abstract][Full Text] [Related]
13. Famotidine in the treatment of gastric and duodenal ulceration: overview of clinical experience. Bianchi Porro G Digestion; 1985; 32 Suppl 1():62-9. PubMed ID: 2866137 [TBL] [Abstract][Full Text] [Related]
14. Treatment of active duodenal ulcers with famotidine. A double-blind comparison with ranitidine. Rohner HG; Gugler R Am J Med; 1986 Oct; 81(4B):13-6. PubMed ID: 2877569 [TBL] [Abstract][Full Text] [Related]
15. Rebamipide may be comparable to H2 receptor antagonist in healing iatrogenic gastric ulcers created by endoscopic mucosal resection: a prospective randomized pilot study. Kim YJ; Cheon JH; Lee SK; Kim JH; Lee YC J Korean Med Sci; 2010 Apr; 25(4):583-8. PubMed ID: 20358002 [TBL] [Abstract][Full Text] [Related]
16. Famotidine therapy for active duodenal ulcers. A multivariate analysis of factors affecting early healing. Reynolds JC Ann Intern Med; 1989 Jul; 111(1):7-14. PubMed ID: 2567589 [TBL] [Abstract][Full Text] [Related]
17. Famotidine: nocturnal administration for gastric ulcer healing. Results of multicenter trials in Austria and Germany. Dammann HG; Walter TA; Hentschel E; Müller P; Simon B Digestion; 1985; 32 Suppl 1():45-50. PubMed ID: 3905468 [TBL] [Abstract][Full Text] [Related]
18. Famotidine in the treatment of duodenal ulcers resistant to other histamine H2-receptor antagonists. Chen PH; Wang TH; Wang CY; Chen CY; Cheng TC; Tsai YT; Siauw CP; Yang KC; Chen GH; Sung JL J Int Med Res; 1989; 17 Suppl 1():25A-31A. PubMed ID: 2566541 [TBL] [Abstract][Full Text] [Related]
19. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. Taha AS; Hudson N; Hawkey CJ; Swannell AJ; Trye PN; Cottrell J; Mann SG; Simon TJ; Sturrock RD; Russell RI N Engl J Med; 1996 May; 334(22):1435-9. PubMed ID: 8618582 [TBL] [Abstract][Full Text] [Related]
20. Famotidine in the management of duodenal ulcer: experience in Italy. Barbara L; Corinaldesi R; Bianchi Porro G; Lazzaroni M; Blasi A; Mangiameli A; Carratelli L; Wilkins A; Cheli R; Bovero E Digestion; 1985; 32 Suppl 1():24-31. PubMed ID: 2866133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]